Case presentation A 2520 g male infant was born by caesarean section at 35 weeks to a 23-year-old gravid 2, para 2 mother. The previous pregnancy had been a live born male infant who had died at 7 weeks of age with pancytopenia and sepsis. The current pregnancy was complicated by fetal hydrops shown by fetal sonogram. At the time of caesarean section, the neonate cried spontaneously and had Apgar scores of 8 at 1 min and 9 at 5 min. The infant was found to have hepatosplenomegaly and scrotal edema and was transferred to the neonatal intensive care unit. The serum ferritin was found to be markedly elevated at 55 755 ng ml À1 (normal 20 to 500). Other abnormal laboratory tests included reduced serum fibrinogen 130 mg per 100 ml (normal 177 to 401 mg per 100 ml), elevated aspartate transaminase 1473 IU l À1 (normal 35 to 140), elevated alanine transaminase 460 IU l À1 (normal 5 to 50), low hematocrit 31.8% (normal 45 to 66), low hemoglobin 11.0 g per 100 ml (normal 14 to 22.5), low platelets 55K per mm 3 (normal 140 to 400) and elevated conjugated bilirubin 2.1 mg per 100 ml (normal 0 to 0.2 mg per 100 ml). Serum triglyceride levels were normal. The soluble interleukin-2 receptor level (sIL-2R) was markedly elevated at 21 500 U ml À1 (normal 334 to 3026). There was virtually absent natural killer (NK) cell function at all dilutions except at 50:1 where 1% activity was detected (normal greater than 20%). A radiograph of the chest and abdomen was taken ( Figure 1 ) and abdominal sonogram (Figure 2 ) was performed.
Denouement and discussion
In this infant, the absence of NK cell activity, hyperferritanemia, hepatosplenomegaly and family history were consistent with familial hemophagocytic lymphohistiocytosis (F-HLH). F-HLH is a rare autosomal recessive condition of T-cell dysfunction characterized by widespread accumulation of lymphocytes and mature macrophages, sometimes with hemophagocytosis, primarily in the liver, spleen, bone marrow and frequently the central nervous system (CNS).
1,2 The imaging findings of hepatosplenomegaly, periportal hyperechogenicity, gallbladder wall thickening, ascites and pleural effusions also were consistent with the diagnosis. 3 This infant had a normal head sonogram, although perivascular and meningeal infiltration are also common findings in F-HLH. 4 Defective NK cell cytotoxicity is a hallmark of this disease. NK cells kill by releasing small cytoplasmic granules of proteins called perforin and granzyme, which cause the target cell to die by apoptosis or necrosis. Deficits in perforin, seen in F-HLH (see below) are associated with a decrease in NK cells. Because NK cell function or activity is decreased in up to 90% of patients, it is one of the most useful laboratory test in the diagnosis of F-HLH.
The incidence of F-HLH is about 1 in 50 000 live births. Hemophagocytic lymphohistiocytosis may be familial and inherited as an autosomal recessive condition, known as F-HLH, or secondary. Secondary hemophagocytic lymphohistiocytosis is usually associated with or preceded by an immune deficiency, severe infection or malignancy. Other conditions associated with the development of secondary hemophagocytic lymphohistiocytosis include leukemia, lymphoma, severe combined immune deficiency syndrome, Chediak-Higashi syndrome, Griscelli syndrome, Wiskott-Aldrich syndrome, lysinuric protein deficiency and Kikuchi disease (histiocytic necrotizing lymphadenitis). 2, 5 Familial hemophagocytic lymphohistiocytosis is associated with four genetic loci. These genetic loci for F-HLH have been labeled FLH1, FLH2, FLH3 and FLH4. FLH1 is located at 9q21.3 and accounts for approximately 50% of cases of F-HLH. The protein encoded by this gene is not yet known.
FHL2 gene, also known as perforin 1 (PRF1) is located at 10q21-22 and accounts for approximately 15 to 20% of cases of F-HLH. PRF1 gene encodes an acid protein known as perforin. Perforin inserts into the membrane of a target cell and induces pore formation. Mutations in PRF1 interfere with pore formation allowing entry of proteases and granzymes, which leads to DNA fragmentation and target cell death. The sequestration of perforin-in cells in F-HLH could also be responsible for the decrease in NK cells expressing perforin in peripheral blood and associated NK cell dysfunction.
FHL3 gene, also known as MUNC13-4, is located at 17q25 and encodes for an amino-acid protein that is needed for secretion of cytolytic granules. Mutations in MUNC13-4 interfere with excretion of cytolytic granules resulting in accumulation of lymphocytes and mature macrophages in cells.
FHL4 gene, known as STX11, is located at 6q24 and encodes a protein, which is responsible for lysosomal vesicle exocytosis. This gene locus is rare except in Turkish and Kurdish patients. 4, 6 The characteristic manifestations of F-HLH include hepatosplenomegaly and petechiae. Neurologic deficits can occur as a result of CNS lymphohistiocytic infiltration with erythrophagocytosis and include depressed level of consciousness, hemiparesis, nuchal rigidity and ataxia. 7 Abnormal laboratory tests include cytopenia, liver dysfunction, hyperlipidemia, hyperferritinemia, elevated cytokines including serum sIL-2R, tumor necrosis factor-a, interferon-g and interleukin-6. 1, 6 Hemophagocytosis by macrophages can be detected in the bone marrow and reticuloendothelial system in approximately two thirds of patients. Familial hemophagocytic lymphohistiocytosis usually presents at a mean age of 2.9 months and is a fatal condition with survival of less than 2 months, if untreated. 2 Recently, PRF1 and MUNC13-4 assays have been able to show that there are rare patients who do not become symptomatic until later in life, including the second decade of life. Currently, the only effective treatment protocols are based on immunochemotherapy (usually etoposide, dexamethasone, cyclosporine and methotrexate), with the goal of achieving disease control, followed by hematopoietic stem cell transplantation (HSCT). Survival after HSCT is approximately 66%. 2 Death is usually related to hemorrhage, opportunistic infection and progressive CNS disease, if untreated.
The imaging findings of F-HLH are typical but nonspecific and reflect the infiltration by T lymphocytes and macrophages, infection and a stimulated immune system. Chest findings can include pulmonary edema, infiltrates and pleural effusions. Osseous findings are usually a late manifestation and include primarily osteopenia and fractures. Abdominal findings include gallbladder wall thickening, ascites, hepatosplenomegaly, prominent thickened or echogenic portal triads and lymphadenopathy. 8 CNS manifestations include meningeal and perivascular infiltration, cortical infiltration and diffuse parenchymal involvement. 8 
